1. Home
  2. MREO vs NWPX Comparison

MREO vs NWPX Comparison

Compare MREO & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • NWPX
  • Stock Information
  • Founded
  • MREO 2015
  • NWPX 1966
  • Country
  • MREO United Kingdom
  • NWPX United States
  • Employees
  • MREO N/A
  • NWPX N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • MREO Health Care
  • NWPX Industrials
  • Exchange
  • MREO Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • MREO 482.5M
  • NWPX 425.3M
  • IPO Year
  • MREO N/A
  • NWPX 1995
  • Fundamental
  • Price
  • MREO $2.50
  • NWPX $40.33
  • Analyst Decision
  • MREO Strong Buy
  • NWPX Hold
  • Analyst Count
  • MREO 6
  • NWPX 1
  • Target Price
  • MREO $7.83
  • NWPX $55.00
  • AVG Volume (30 Days)
  • MREO 1.5M
  • NWPX 84.4K
  • Earning Date
  • MREO 03-26-2025
  • NWPX 04-30-2025
  • Dividend Yield
  • MREO N/A
  • NWPX N/A
  • EPS Growth
  • MREO N/A
  • NWPX 62.68
  • EPS
  • MREO N/A
  • NWPX 3.40
  • Revenue
  • MREO $1,000,000.00
  • NWPX $492,548,000.00
  • Revenue This Year
  • MREO N/A
  • NWPX $2.48
  • Revenue Next Year
  • MREO N/A
  • NWPX $4.49
  • P/E Ratio
  • MREO N/A
  • NWPX $12.04
  • Revenue Growth
  • MREO N/A
  • NWPX 10.85
  • 52 Week Low
  • MREO $2.25
  • NWPX $31.16
  • 52 Week High
  • MREO $5.02
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • MREO 38.26
  • NWPX 30.94
  • Support Level
  • MREO $2.39
  • NWPX $39.29
  • Resistance Level
  • MREO $2.59
  • NWPX $41.51
  • Average True Range (ATR)
  • MREO 0.17
  • NWPX 1.79
  • MACD
  • MREO 0.02
  • NWPX -0.44
  • Stochastic Oscillator
  • MREO 39.87
  • NWPX 11.08

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About NWPX Northwest Pipe Company

Northwest Pipe Co is a manufacturer of water-related infrastructure products. The company has two operating segments; Engineered Steel Pressure Pipe segment manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. These products are also used for hydroelectric power systems, wastewater systems, seismic resiliency, and other applications, and Precast Infrastructure and Engineered Systems segment manufacture stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration, and other environmental and engineered solutions.

Share on Social Networks: